V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 10061179 | 10016292 | EE101 | 7600 | X731 | 5 | 2018-02-26 | PEMBROLIZUMAB | 10350371 | 10000869 | 10001319 |
| 10061180 | 10016292 | EGSSF | 10 | null | 5 | 2018-02-26 | BORTEZOMIB | 10350371 | 10000869 | 10001319 |
| 10061181 | 10016292 | EOY14 | 150 | null | 1 | 2018-02-26 | LIPOSOMAL DOXORUBICIN | 10350371 | 10000869 | 10001319 |
| 10061182 | 10016292 | EWR01 | 2 | null | 1 | 2018-02-26 | VINCRISTINE | 10350371 | 10000869 | 10001319 |
| 10061183 | 10016292 | ERA20 | 100 | X724 | 2 | 2018-02-26 | THALIDOMIDE | 10350371 | 10000869 | 10001319 |
| 10061184 | 10016292 | EQQU0 | 2.25 | X723 | 5 | 2018-02-26 | VINCRISTINE | 10350371 | 10000869 | 10001319 |
| 10061185 | 10016292 | EWR09 | 200 | null | 1 | 2018-02-26 | CYCLOPHOSPHAMIDE | 10350371 | 10000869 | 10001319 |
| 10061186 | 10016292 | ENCAZ | 200 | X724 | 1 | 2018-02-26 | NOT CHEMO | 10350371 | 10000869 | 10001319 |
| 10061187 | 10016292 | EKA | 70 | null | 1 | 2018-02-26 | STEROID | 10350371 | 10000869 | 10001319 |
| 10061188 | 10016292 | EX950 | 2500 | null | 2 | 2018-02-26 | CAPECITABINE | 10350371 | 10000869 | 10001319 |
| 10061189 | 10016292 | eke10 | 1000 | X721 | 1 | 2018-02-26 | PEMBROLIZUMAB | 10350371 | 10000869 | 10001319 |
| 10061190 | 10016293 | EOX02 | 800 | X731 | 2 | 2018-10-26 | RITUXIMAB | 10350410 | 10000870 | 10001321 |
| 10061191 | 10016293 | E1UZ0 | 2.5 | X724 | 1 | 2018-11-02 | BORTEZOMIB | 10350410 | 10000870 | 10001321 |
| 10061192 | 10016293 | EUH | 2 | X721 | 1 | 2018-11-02 | VINCRISTINE | 10350410 | 10000870 | 10001321 |
| 10061193 | 10016293 | EWR01 | 100 | null | 1 | 2018-11-02 | DOXORUBICIN | 10350410 | 10000870 | 10001321 |
| 10061194 | 10016293 | EGK02 | 100 | X731 | 2 | 2018-11-02 | NOT CHEMO | 10350410 | 10000870 | 10001321 |
| 10061195 | 10016293 | EU8 | 700 | null | 1 | 2018-11-02 | CYTARABINE | 10350410 | 10000870 | 10001321 |
| 10061196 | 10016293 | EX950 | 1000 | X724 | 1 | 2018-11-02 | NOT CHEMO | 10350410 | 10000870 | 10001321 |
| 10061197 | 10016293 | EJU01 | 100 | X722 | 1 | 2018-11-02 | EPIRUBICIN | 10350410 | 10000870 | 10001321 |
| 10061198 | 10016293 | EN201 | 122.5 | null | 1 | 2018-11-02 | FLUOROURACIL | 10350410 | 10000870 | 10001321 |
| 10061199 | 10016293 | ECL02 | 2500 | X723 | 2 | 2018-11-02 | NOT CHEMO | 10350410 | 10000870 | 10001321 |
| 10061200 | 10016294 | EC5QE | 1900 | null | 2 | 2018-06-23 | GEMCITABINE | 10350410 | 10000870 | 10001323 |
| 10061201 | 10016294 | ERS12 | 1.7 | null | 2 | 2018-06-23 | BORTEZOMIB | 10350410 | 10000870 | 10001323 |
| 10061202 | 10016295 | EN201 | 1700 | X723 | null | 2017-06-22 | GEMCITABINE | 10350742 | 10000871 | 10001324 |
| 10061203 | 10016296 | EK1PP | null | X722 | 2 | 2019-01-22 | PEMBROLIZUMAB | 10350751 | 10000872 | 10001325 |
| 10061204 | 10016296 | EDZ | 2.2 | X723 | 5 | 2019-01-22 | BORTEZOMIB | 10350751 | 10000872 | 10001325 |
| 10061205 | 10016296 | EOQ01 | 80 | null | 2 | 2019-01-22 | STEROID | 10350751 | 10000872 | 10001325 |
| 10061206 | 10016296 | EUH | 150 | X723 | 1 | 2019-01-22 | DOXORUBICIN | 10350751 | 10000872 | 10001325 |
| 10061207 | 10016296 | EN201 | 1300 | X724 | 1 | 2019-01-28 | GEMCITABINE | 10350751 | 10000872 | 10001325 |
| 10061208 | 10016297 | ECL01 | 200 | X721 | 2 | 2015-11-13 | CYCLOPHOSPHAMIDE | 10350855 | 10000873 | 10001326 |
| 10061209 | 10016298 | EAF01 | 950 | X723 | 1 | 2015-08-21 | IBRUTINIB | 10351087 | 10000874 | 10001328 |
| 10061210 | 10016298 | EII | 120 | null | 1 | 2015-08-21 | CYCLOPHOSPHAMIDE | 10351087 | 10000874 | 10001328 |
| 10061211 | 10016298 | EQ8 | 300 | X723 | 2 | 2015-08-21 | NOT CHEMO | 10351087 | 10000874 | 10001328 |
| 10061212 | 10016298 | EOQ01 | 2100 | X723 | 1 | 2015-08-21 | DOXORUBICIN | 10351087 | 10000874 | 10001328 |
| 10061213 | 10016299 | EC5QE | 200 | null | 2 | 2017-08-02 | TRIAL | 10351261 | 10000875 | 10001329 |
| 10061214 | 10016299 | EES02 | 10 | X723 | 2 | 2017-08-03 | BORTEZOMIB | 10351261 | 10000875 | 10001329 |
| 10061215 | 10016299 | EQ8 | 8 | X723 | 2 | 2017-08-03 | NOT CHEMO | 10351261 | 10000875 | 10001329 |
| 10061216 | 10016300 | EC5QE | 200 | null | 2 | 2017-01-21 | RITUXIMAB | 10351385 | 10000877 | 10001331 |
| 10061217 | 10016300 | ERZ21 | 2.2 | X723 | 5 | 2017-01-28 | NOT CHEMO | 10351385 | 10000877 | 10001331 |
| 10061218 | 10016300 | EAD51 | 6 | X723 | 2 | 2017-01-28 | NOT CHEMO | 10351385 | 10000877 | 10001331 |
| 10061219 | 10016301 | ETG | 8 | null | 1 | 2018-10-05 | TRIAL | 10351533 | 10000879 | 10001333 |
| 10061220 | 10016301 | EWM30 | 900 | X723 | 5 | 2018-10-05 | EPIRUBICIN | 10351533 | 10000879 | 10001333 |
| 10061221 | 10016301 | EN201 | 100 | X723 | 2 | 2018-10-06 | STEROID | 10351533 | 10000879 | 10001333 |
| 10061222 | 10016302 | ETG | 100 | null | 2 | 2018-07-11 | GEMCITABINE | 10351548 | 10000880 | 10001334 |
| 10061223 | 10016303 | ETG | 1400 | null | 1 | 2018-05-11 | RUXOLITINIB | 10351551 | 10000881 | 10001335 |
| 10061224 | 10016303 | EDZ | 2.1 | X724 | 2 | 2018-05-18 | BORTEZOMIB | 10351551 | 10000881 | 10001335 |
| 10061225 | 10016303 | EN201 | 10 | X723 | 2 | 2018-05-18 | NOT CHEMO | 10351551 | 10000881 | 10001335 |
| 10061226 | 10016304 | ETG | 1400 | null | 1 | 2015-04-16 | NOT CHEMO | 10351591 | 10000882 | 10001336 |
| 10061227 | 10016304 | EJN | 10 | X724 | 5 | 2015-04-16 | NOT CHEMO | 10351591 | 10000882 | 10001336 |
| 10061228 | 10016304 | EYG01 | 2 | X723 | 1 | 2015-04-16 | VINCRISTINE | 10351591 | 10000882 | 10001336 |